JP2011503137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503137A5 JP2011503137A5 JP2010533548A JP2010533548A JP2011503137A5 JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5 JP 2010533548 A JP2010533548 A JP 2010533548A JP 2010533548 A JP2010533548 A JP 2010533548A JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5
- Authority
- JP
- Japan
- Prior art keywords
- vitro
- interleukin
- incubating
- analogues
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 5
- 238000000338 in vitro Methods 0.000 claims 4
- 244000005700 microbiome Species 0.000 claims 4
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 2
- 102000000589 Interleukin-1 Human genes 0.000 claims 2
- 108010002352 Interleukin-1 Proteins 0.000 claims 2
- 102000004889 Interleukin-6 Human genes 0.000 claims 2
- 108090001005 Interleukin-6 Proteins 0.000 claims 2
- 102000004890 Interleukin-8 Human genes 0.000 claims 2
- 108090001007 Interleukin-8 Proteins 0.000 claims 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 2
- 229940047120 colony stimulating factors Drugs 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 229940100601 interleukin-6 Drugs 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 229940096397 interleukin-8 Drugs 0.000 claims 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07120713A EP2060586A1 (en) | 2007-11-14 | 2007-11-14 | New synthetic arginine substituted peptides and their use |
| US99006607P | 2007-11-26 | 2007-11-26 | |
| PCT/EP2008/065186 WO2009062898A1 (en) | 2007-11-14 | 2008-11-10 | New synthetic arginine substituted peptides and their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011503137A JP2011503137A (ja) | 2011-01-27 |
| JP2011503137A5 true JP2011503137A5 (enExample) | 2012-01-05 |
Family
ID=39226731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533548A Pending JP2011503137A (ja) | 2007-11-14 | 2008-11-10 | 新規のアルギニン置換ペプチド及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7928185B2 (enExample) |
| EP (2) | EP2060586A1 (enExample) |
| JP (1) | JP2011503137A (enExample) |
| CN (1) | CN101878226B (enExample) |
| AU (1) | AU2008323041A1 (enExample) |
| CA (1) | CA2703894A1 (enExample) |
| DK (1) | DK2212352T3 (enExample) |
| MX (1) | MX2010005280A (enExample) |
| WO (1) | WO2009062898A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2481751A1 (en) | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
| WO2014090905A1 (en) * | 2012-12-11 | 2014-06-19 | Imaxio | Modified coiled coil type proteins having improved properties |
| JP2016520534A (ja) | 2013-03-18 | 2016-07-14 | イマクシオImaxio | インフルエンザ核タンパク質ワクチン |
| US9850278B2 (en) | 2013-04-25 | 2017-12-26 | Carmel-Haifa University Economic Corp. | Synthetic anti-inflammatory peptides and use thereof |
| US12295990B2 (en) | 2018-11-09 | 2025-05-13 | The Wistar Institute Of Anatomy And Biology | Use of lactoferrin for generating myeloid-derived suppressor cells |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2818056B2 (ja) | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
| US5656591A (en) | 1992-01-23 | 1997-08-12 | Morinaga Milk Industry Co., Ltd. | Antimicrobial agents and method for treating products therewith |
| JP3347819B2 (ja) | 1993-06-28 | 2002-11-20 | 森永乳業株式会社 | 抗菌性ペプチドの精製方法 |
| JP3529423B2 (ja) | 1994-04-01 | 2004-05-24 | 森永乳業株式会社 | 抗菌性ペプチドの製造方法 |
| JP3812957B2 (ja) | 1994-08-02 | 2006-08-23 | 森永乳業株式会社 | 角膜損傷治療剤 |
| JPH08143468A (ja) | 1994-11-17 | 1996-06-04 | Morinaga Milk Ind Co Ltd | 抗潰瘍剤 |
| JP2001504447A (ja) | 1996-08-12 | 2001-04-03 | エイプラス サイエンス インベスト アーベー | ラクトフェリンおよび/またはラクトフェリシンでの、感染、炎症および/または腫瘍の処置および予防 |
| SE9804614A0 (en) * | 1998-07-06 | 2000-01-07 | A+ Science Invest Ab | New peptides and use thereof |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| CA2388910C (en) * | 1999-11-11 | 2008-10-07 | Am-Pharma B.V. | Antimicrobial activity of the first cationic cluster of human lactoferrin |
| US7183381B2 (en) | 2004-10-26 | 2007-02-27 | Agennix, Inc. | Composition of lactoferrin related peptides and uses thereof |
-
2007
- 2007-11-14 EP EP07120713A patent/EP2060586A1/en not_active Withdrawn
-
2008
- 2008-11-10 JP JP2010533548A patent/JP2011503137A/ja active Pending
- 2008-11-10 DK DK08850370.1T patent/DK2212352T3/da active
- 2008-11-10 US US12/292,030 patent/US7928185B2/en not_active Expired - Fee Related
- 2008-11-10 WO PCT/EP2008/065186 patent/WO2009062898A1/en not_active Ceased
- 2008-11-10 AU AU2008323041A patent/AU2008323041A1/en not_active Abandoned
- 2008-11-10 MX MX2010005280A patent/MX2010005280A/es active IP Right Grant
- 2008-11-10 CA CA2703894A patent/CA2703894A1/en not_active Abandoned
- 2008-11-10 CN CN200880114504.9A patent/CN101878226B/zh not_active Expired - Fee Related
- 2008-11-10 EP EP08850370.1A patent/EP2212352B1/en not_active Not-in-force
-
2011
- 2011-04-19 US US13/089,680 patent/US8815812B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rada et al. | Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin | |
| Chen et al. | The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans | |
| JP2011503137A5 (enExample) | ||
| Maris et al. | Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers | |
| Tanabe et al. | Airway goblet cells secrete pro-inflammatory cytokines, chemokines, and growth factors | |
| Sayers et al. | Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes | |
| CN112106705B (zh) | 一种评价药物预防病毒性肺炎效果的方法 | |
| WO2023061512A1 (zh) | 体外细胞因子风暴模型及其构建方法和应用 | |
| Lora et al. | FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines | |
| CN104928288A (zh) | 一种用于我国养殖对虾虾肝肠胞虫感染早期预警的套式引物及其应用 | |
| CN105412112A (zh) | Roquefortine F在制备治疗慢性阻塞性肺疾病药物中的应用 | |
| Ghassemi-Golezani et al. | Influence of hydro-priming on reserve utilization of differentially aged chickpea seeds | |
| CN102154185B (zh) | 一株产咖啡酸的刺五加内生细菌 | |
| Lee et al. | Evidence-guided optimization of herbal formula Cheong-Hwa-Bo-Um-Tang using multiplex cytokine profiling | |
| sites Prevalence et al. | First reported detection of Batrachochytrium dendrobatidis in Florida, USA | |
| CN119827767B (zh) | 泛素特异性蛋白酶usp4在治疗急性肺损伤/急性呼吸窘迫综合征中的应用 | |
| CN204540371U (zh) | 从王台中取幼虫的多排镊子 | |
| CN101057840A (zh) | Vam3在制备治疗慢性阻塞性肺疾病的药物中的应用 | |
| CN102703327B (zh) | 产乌头碱的枝孢菌xj-ac03及其应用 | |
| CHO et al. | Comparison of Cytokine and Chemokine Production and Activation of NF-kappaB in RSV-and Adenovirus-infected Bronchial Epithelial Cells | |
| CN102988377B (zh) | Houttuynoid D在制备治疗慢性阻塞性肺疾病的药物中的应用 | |
| CN102988383B (zh) | Houttuynoid E在制备治疗慢性阻塞性肺疾病的药物中的应用 | |
| Caprio et al. | The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa | |
| CN103120672A (zh) | Aphanamixoid A在治疗慢性阻塞性肺疾病的药物中的应用 | |
| Campbell et al. | Cytokine and chemokine interactions in allergic airway inflammation |